Expression of programmed death ligand-1 predicts poor outcome in nasopharyngeal carcinoma

Programmed death ligand-1 (PD-L1) is a potentially important tumor immunotherapy target. However, whether PD-L1 expression is associated with survival in nasopharyngeal carcinoma (NPC) remains controversial. The aim of the present study was to investigate the association between PD-L1 expression and...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mol Clin Oncol
Main Authors: Li, Ying-Fei, Ding, Jian-Wu, Liao, Ling-Min, Zhang, Zhi-Lin, Liao, Shou-Sheng, Wu, Ying, Zhou, Dan-Yang, Liu, An-Wen, Huang, Long
Formato: Artigo
Idioma:Inglês
Publicado em: D.A. Spandidos 2017
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5530303/
https://ncbi.nlm.nih.gov/pubmed/28781814
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2017.1318
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados